These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, van der Gaag R. Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908 [Abstract] [Full Text] [Related]
8. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K. Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881 [Abstract] [Full Text] [Related]
10. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease. de Bellis A, Perrino S, Coronella C, Sansone D, Ruocco G, Tirelli G, Di Martino S, Conte M, Bellastella G, Wall JR, Bellastella A, Bizzarro A. Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332 [Abstract] [Full Text] [Related]
11. [A clinical analysis of Graves' ophthalmopathy and ophthalmic Graves' disease]. Liao ZQ. Zhonghua Yan Ke Za Zhi; 1992 Jul; 28(4):236-9. PubMed ID: 1299571 [Abstract] [Full Text] [Related]
12. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids]. Cirić J, Zarković M, Stojanović M, Pepenezić Z, Randjelović G, Gligorović M, Trbojević B, Drezgić M, Nesović M. Srp Arh Celok Lek; 2000 Jul; 128(5-6):179-83. PubMed ID: 11089418 [Abstract] [Full Text] [Related]